Palvella Therapeutics (PVLA) EBIT Margin Growth (3y) (2017 - 2024)
Palvella Therapeutics (PVLA) EBIT Margin Growth (3y) (2017 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Palvella Therapeutics |
1.49 Bn |
1.23 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2024 |
-327,995.00 |
| Sep 30, 2023 |
36,646.00 |
| Jun 30, 2023 |
5,168.00 |
| Mar 31, 2023 |
-77,211.00 |
| Sep 30, 2022 |
-469,702.00 |
| Jun 30, 2022 |
-12,617.00 |
| Mar 31, 2022 |
5,716.00 |
| Dec 31, 2021 |
188,647.00 |
| Sep 30, 2021 |
-58,963.00 |
| Jun 30, 2021 |
-64,070.00 |
| Mar 31, 2021 |
15,704.00 |
| Dec 31, 2020 |
-69,696.00 |
| Sep 30, 2020 |
-31,028.00 |
| Jun 30, 2020 |
38,446.00 |
| Mar 31, 2020 |
56,705.00 |
| Dec 31, 2019 |
19,139.00 |
| Sep 30, 2019 |
76,774.00 |
| Jun 30, 2019 |
31,082.00 |
| Mar 31, 2019 |
22,638.00 |
| Dec 31, 2018 |
-271,408.00 |
